Cost-effectiveness of mechanical thrombectomy for acute ischemic stroke in Brazil: Results from the RESILIENT trial.
Ana Claudia de SouzaSheila O MartinsCarisi Anne PolanczykDenizar Vianna AraújoAna Paula Beck da Silva EtgesBruna Stella ZanottoJeruza Lavanholi NeyeloffLeonardo Augusto CarboneraMárcia Lorena Fagundes ChavesJoão José Freitas de CarvalhoLetícia Costa RebelloDaniel Giansante AbudLucas Scotta CabralFabrício O LimaFrancisco Mont'AlvernePedro Sc MagalhãesHenrique DiegolliJuliana SafanelliThales André Silveira SalvettiBruno de Sousa Mendes ParenteMichel Eli FruditGisele Sampaio SilvaOctavio Marques Pontes NetoRaul G NogueiraPublished in: International journal of stroke : official journal of the International Stroke Society (2021)
The intervention's clear long-term benefits offset the initially higher costs of mechanical thrombectomy in the Brazilian public healthcare system. Such therapy is likely to be cost-effective and these results were crucial to incorporate mechanical thrombectomy in the Brazilian public stroke centers.